We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Letters to the Editor |

No Allelic Association Between Bipolar Affective Disorder and the Tryptophan Hydroxylase Gene

Andrew McQuillin, PhD; Jacob Lawrence, MBBS, MRCPsych; Gursharan Kalsi, BSc; Andrew Chen, MD, PhD; Hugh Gurling, MD, MPhil, FRCPsych; David Curtis, MD, MRCPsych
Arch Gen Psychiatry. 1999;56(1):99-100. doi:.
Text Size: A A A
Published online


We have attempted to replicate recently published results showing an association between the "A" allele of a restriction fragment length polymorphism in intron 7 of the tryptophan hydroxylase (TPH) gene and manic-depressive illness.1 Polymorphisms in this gene have also been found to be associated with suicidal behavior in depressed patients.2 The TPH gene is the rate-limiting enzyme in the serotonin biosynthetic pathway3 and is localized on the short arm of chromosome 11, which is a region at which we have reported positive lod scores in a genetic linkage analysis of 23 multiply affected bipolar and unipolar affective disorder families.4 We used a case-control design and studied 279 bipolar cases and 315 controls who were selected for having English, Irish, Welsh, or Scottish ancestry. Allele freqencies were very similar to previously published rates in European populations and were also very similar in the bipolar and control groups (0.39 vs 0.41). We conclude that it is unlikely that this polymorphism has any major effect on susceptibility to bipolar affective disorder, at least in the population we have studied.


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





January 1, 1999
Frank Bellivier, MD; Marion Leboyer, MD, PhD; Philippe Courtet, MD; Josue Feingold, MD, PhD; Catherine Buresi, MD, PhD; Alain Malafosse, MD, PhD
Arch Gen Psychiatry. 1999;56(1):101. doi:.
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

24 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...